A pharmacological analysis of food intake regulation in rats treated neonatally with monosodium L-glutamate (MSG)

Ralph Dawson, David R. Wallace, Steven M. Gabriel

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Studies were conducted to examine deficits in food intake regulation in MSG-treated rats that result from known or suspected damage to neurotransmitter systems involved in feeding. Male rats were injected with either MSG (4 mg/g) or sodium chloride on postnatal days 2 and 4 (MSG-Lo) or postnatal days 2, 4, 6 and 8 (MSG-Hi). As adults, MSG-treated and control rats (n = 12/group) were examined for deficits in pharmacologically elicited feeding and other measures of food intake regulation. A second group of MSG-treated (n = 9/group) and control rats (n = 12) were used to measure basal blood pressure and nociceptive reactivity in adulthood. Organ weights, body weight and neuropeptide Y (NPY) content in brain regions were determined at the end of the study. MSG-Hi rats consumed significantly less food than controls during the dark part of the light cycle. Both MSG-Hi and MSG-Lo groups ate significantly less food than controls after a 48-hour fast. MSG-Hi and MSG-Lo rats consumed significantly less food than controls in response to 1.0 mg/kg morphine. MSG-Hi rats consumed significantly less food than controls during the dark phase and significantly more food than controls during the light phase in response to naloxone (1.0 mg/kg). MSG-Lo ate significantly more than controls in response to 0.1 mg/kg guanfacine. MSG-Hi and MSG-Lo showed a significant attenuation in diazepam-stimulated feeding when compared to controls. Blood pressure was significantly lower in both MSG-Hi and MSG-Lo rats compared to controls. Tail flick latencies were not altered by MSG-treatment. Both doses of MSG produced significant reductions in anterior pituitary, testicular, adrenal and kidney weights relative to the controls. NPY content was significantly reduced in the hypothalamus of MSG-treated (Hi and Lo) rats, but not in other brain regions. The relationship between MSG-induced neurotoxicity and the behavioral and neurochemical deficits of MSG-treated rats was discussed.

Original languageEnglish
Pages (from-to)391-398
Number of pages8
JournalPharmacology, Biochemistry and Behavior
Volume32
Issue number2
DOIs
StatePublished - Feb 1989

Fingerprint

Appetite Regulation
Sodium Glutamate
Rats
Glutamic Acid
Pharmacology
Food
Rat control
Neuropeptide Y
Blood pressure
Brain
Guanfacine

Keywords

  • Arcuate nucleus
  • Monosodium L-glutamate
  • Neuropeptide Y
  • Neuropharmacology of feeding
  • Opioids and feeding
  • α-Adrenoceptor-stimulated feeding

Cite this

@article{e21c937ab32c439493ddd55540f9fea8,
title = "A pharmacological analysis of food intake regulation in rats treated neonatally with monosodium L-glutamate (MSG)",
abstract = "Studies were conducted to examine deficits in food intake regulation in MSG-treated rats that result from known or suspected damage to neurotransmitter systems involved in feeding. Male rats were injected with either MSG (4 mg/g) or sodium chloride on postnatal days 2 and 4 (MSG-Lo) or postnatal days 2, 4, 6 and 8 (MSG-Hi). As adults, MSG-treated and control rats (n = 12/group) were examined for deficits in pharmacologically elicited feeding and other measures of food intake regulation. A second group of MSG-treated (n = 9/group) and control rats (n = 12) were used to measure basal blood pressure and nociceptive reactivity in adulthood. Organ weights, body weight and neuropeptide Y (NPY) content in brain regions were determined at the end of the study. MSG-Hi rats consumed significantly less food than controls during the dark part of the light cycle. Both MSG-Hi and MSG-Lo groups ate significantly less food than controls after a 48-hour fast. MSG-Hi and MSG-Lo rats consumed significantly less food than controls in response to 1.0 mg/kg morphine. MSG-Hi rats consumed significantly less food than controls during the dark phase and significantly more food than controls during the light phase in response to naloxone (1.0 mg/kg). MSG-Lo ate significantly more than controls in response to 0.1 mg/kg guanfacine. MSG-Hi and MSG-Lo showed a significant attenuation in diazepam-stimulated feeding when compared to controls. Blood pressure was significantly lower in both MSG-Hi and MSG-Lo rats compared to controls. Tail flick latencies were not altered by MSG-treatment. Both doses of MSG produced significant reductions in anterior pituitary, testicular, adrenal and kidney weights relative to the controls. NPY content was significantly reduced in the hypothalamus of MSG-treated (Hi and Lo) rats, but not in other brain regions. The relationship between MSG-induced neurotoxicity and the behavioral and neurochemical deficits of MSG-treated rats was discussed.",
keywords = "Arcuate nucleus, Monosodium L-glutamate, Neuropeptide Y, Neuropharmacology of feeding, Opioids and feeding, α-Adrenoceptor-stimulated feeding",
author = "Ralph Dawson and Wallace, {David R.} and Gabriel, {Steven M.}",
year = "1989",
month = "2",
doi = "10.1016/0091-3057(89)90168-8",
language = "English",
volume = "32",
pages = "391--398",
journal = "Pharmacology, Biochemistry and Behavior",
issn = "0091-3057",
publisher = "Elsevier Inc.",
number = "2",

}

A pharmacological analysis of food intake regulation in rats treated neonatally with monosodium L-glutamate (MSG). / Dawson, Ralph; Wallace, David R.; Gabriel, Steven M.

In: Pharmacology, Biochemistry and Behavior, Vol. 32, No. 2, 02.1989, p. 391-398.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A pharmacological analysis of food intake regulation in rats treated neonatally with monosodium L-glutamate (MSG)

AU - Dawson, Ralph

AU - Wallace, David R.

AU - Gabriel, Steven M.

PY - 1989/2

Y1 - 1989/2

N2 - Studies were conducted to examine deficits in food intake regulation in MSG-treated rats that result from known or suspected damage to neurotransmitter systems involved in feeding. Male rats were injected with either MSG (4 mg/g) or sodium chloride on postnatal days 2 and 4 (MSG-Lo) or postnatal days 2, 4, 6 and 8 (MSG-Hi). As adults, MSG-treated and control rats (n = 12/group) were examined for deficits in pharmacologically elicited feeding and other measures of food intake regulation. A second group of MSG-treated (n = 9/group) and control rats (n = 12) were used to measure basal blood pressure and nociceptive reactivity in adulthood. Organ weights, body weight and neuropeptide Y (NPY) content in brain regions were determined at the end of the study. MSG-Hi rats consumed significantly less food than controls during the dark part of the light cycle. Both MSG-Hi and MSG-Lo groups ate significantly less food than controls after a 48-hour fast. MSG-Hi and MSG-Lo rats consumed significantly less food than controls in response to 1.0 mg/kg morphine. MSG-Hi rats consumed significantly less food than controls during the dark phase and significantly more food than controls during the light phase in response to naloxone (1.0 mg/kg). MSG-Lo ate significantly more than controls in response to 0.1 mg/kg guanfacine. MSG-Hi and MSG-Lo showed a significant attenuation in diazepam-stimulated feeding when compared to controls. Blood pressure was significantly lower in both MSG-Hi and MSG-Lo rats compared to controls. Tail flick latencies were not altered by MSG-treatment. Both doses of MSG produced significant reductions in anterior pituitary, testicular, adrenal and kidney weights relative to the controls. NPY content was significantly reduced in the hypothalamus of MSG-treated (Hi and Lo) rats, but not in other brain regions. The relationship between MSG-induced neurotoxicity and the behavioral and neurochemical deficits of MSG-treated rats was discussed.

AB - Studies were conducted to examine deficits in food intake regulation in MSG-treated rats that result from known or suspected damage to neurotransmitter systems involved in feeding. Male rats were injected with either MSG (4 mg/g) or sodium chloride on postnatal days 2 and 4 (MSG-Lo) or postnatal days 2, 4, 6 and 8 (MSG-Hi). As adults, MSG-treated and control rats (n = 12/group) were examined for deficits in pharmacologically elicited feeding and other measures of food intake regulation. A second group of MSG-treated (n = 9/group) and control rats (n = 12) were used to measure basal blood pressure and nociceptive reactivity in adulthood. Organ weights, body weight and neuropeptide Y (NPY) content in brain regions were determined at the end of the study. MSG-Hi rats consumed significantly less food than controls during the dark part of the light cycle. Both MSG-Hi and MSG-Lo groups ate significantly less food than controls after a 48-hour fast. MSG-Hi and MSG-Lo rats consumed significantly less food than controls in response to 1.0 mg/kg morphine. MSG-Hi rats consumed significantly less food than controls during the dark phase and significantly more food than controls during the light phase in response to naloxone (1.0 mg/kg). MSG-Lo ate significantly more than controls in response to 0.1 mg/kg guanfacine. MSG-Hi and MSG-Lo showed a significant attenuation in diazepam-stimulated feeding when compared to controls. Blood pressure was significantly lower in both MSG-Hi and MSG-Lo rats compared to controls. Tail flick latencies were not altered by MSG-treatment. Both doses of MSG produced significant reductions in anterior pituitary, testicular, adrenal and kidney weights relative to the controls. NPY content was significantly reduced in the hypothalamus of MSG-treated (Hi and Lo) rats, but not in other brain regions. The relationship between MSG-induced neurotoxicity and the behavioral and neurochemical deficits of MSG-treated rats was discussed.

KW - Arcuate nucleus

KW - Monosodium L-glutamate

KW - Neuropeptide Y

KW - Neuropharmacology of feeding

KW - Opioids and feeding

KW - α-Adrenoceptor-stimulated feeding

UR - http://www.scopus.com/inward/record.url?scp=0024406067&partnerID=8YFLogxK

U2 - 10.1016/0091-3057(89)90168-8

DO - 10.1016/0091-3057(89)90168-8

M3 - Article

C2 - 2726997

AN - SCOPUS:0024406067

VL - 32

SP - 391

EP - 398

JO - Pharmacology, Biochemistry and Behavior

JF - Pharmacology, Biochemistry and Behavior

SN - 0091-3057

IS - 2

ER -